A novel peptide targeting Clec9a on dendritic cell for cancer immunotherapy

Dendritic cells (DCs) are professional antigen-presenting cells with antigen recognition molecules on the surface. Clec9a is selectively expressed on mouse CD8a(+) DCs and CD103(+) DCs subsets, which are functionally similar to human BDCA3(+) DCs. It is reported that Clec9a is responsible for the an...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Zhongyi, Wu, Yahong, Du, Jiangfeng, Li, Guodong, Wang, Shengdian, Cao, Wenpeng, Zhou, Xiuman, Wu, Chunjing, Zhang, Dan, Jing, Xueli, Li, Yifan, Wang, Hongfei, Gao, Yanfeng, Qi, Yuanming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130018/
https://www.ncbi.nlm.nih.gov/pubmed/27250027
http://dx.doi.org/10.18632/oncotarget.9624

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130018/
https://www.ncbi.nlm.nih.gov/pubmed/27250027
http://dx.doi.org/10.18632/oncotarget.9624

Ejemplares similares